How effective is Celexa for Attention Deficit Hyperactivity Disorder? (a real world drug study)
Summary:
Overall ratings: 2.4/5 Long term ratings: 2/5
This is a phase IV clinical study of how effective Celexa (citalopram hydrobromide) is for Attention deficit hyperactivity disorder and for what kind of people. The study is created by eHealthMe from 12 Celexa users and is updated continuously.
What is Celexa?
Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 610 drugs and 1,393 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.
12 people are studied for taking Celexa in Attention deficit hyperactivity disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Celexa effectiveness for Attention deficit hyperactivity disorder (number of people):
Overall:
- not at all: 3
- somewhat: 2
- moderate: 6
- high: 1
- very high: 0
Long Term:
- not at all: 1
- somewhat: 0
- moderate: 1
- high: 0
- very high: 0
Gender of people who take Celexa for Attention deficit hyperactivity disorder *:
- female: 66.67 %
- male: 33.33 %
Age of people who take Celexa for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 8.33 %
- 10-19: 16.67 %
- 20-29: 16.67 %
- 30-39: 33.33 %
- 40-49: 25.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Who find Celexa more effective for Attention Deficit Hyperactivity Disorder?
Gender of people who take Celexa for Attention deficit hyperactivity disorder *:
- female: 100 %
- male: 0.0 %
Age of people who take Celexa for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Celexa?
- You can start a phase IV clinical trial to monitor Celexa safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Celexa (56,390 reports)
Treatments, associated drugs and conditions:
- Attention deficit hyperactivity disorder (120,336 reports)
How the study uses the data?
The study is based on citalopram hydrobromide (the active ingredients of Celexa) and Celexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mantle Cell Lymphoma and Abdominal Pain - a second ago
- Drug interactions of Cetirizine Hydrochloride and Tysabri - 5 seconds ago
- Drug interactions of Zithromax and Fulvestrant - 39 seconds ago
- Could Ginkgo cause Agranulocytosis? - 40 seconds ago
- Could Copegus cause Restless Leg Syndrome? - 46 seconds ago
- Drug interactions of Tazidime and Rapamune - 58 seconds ago
- Gastritis and Cognitive Disorder - a minute ago
- Could Olanzapine cause Birth Control? - a minute ago
- Crohn'S Disease and Retinal Oedema - a minute ago
- Could Posaconazole cause Itching? - a minute ago